Here are the 424B prospectus supplements from Inspire Veterinary Partners, Inc. (IVP) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow IVP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IVP filings page.
Inspire Veterinary Partners is registering up to 200,000,000 shares of Class A common stock for resale by a single selling stockholder. The shares come from two secured convertible promissory notes and related share consideration, so conversions and note-related issuances could significantly increase the public float.
The company operates 14 veterinary hospitals in nine states but has a history of losses, including a net loss of $14,264,261 in 2024 and an accumulated deficit of $36,350,281. As of December 31, 2024, it held $723,690 in cash and restricted cash, and its auditors raised substantial doubt about its ability to continue as a going concern. Inspire’s stock has been delisted from Nasdaq and now trades on the OTCQB at $0.01 per share, and authorized common shares were increased to 700,000,000, highlighting both financing needs and potential dilution for existing holders.